Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2012 1
2014 2
2015 1
2016 1
2018 4
2019 5
2020 2
2021 6
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA. Al-Hendy A, et al. N Engl J Med. 2021 Feb 18;384(7):630-642. doi: 10.1056/NEJMoa2008283. N Engl J Med. 2021. PMID: 33596357 Free PMC article. Clinical Trial.
Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA. Al-Hendy A, et al. Obstet Gynecol. 2022 Dec 1;140(6):920-930. doi: 10.1097/AOG.0000000000004988. Epub 2022 Nov 2. Obstet Gynecol. 2022. PMID: 36357960 Free PMC article. Clinical Trial.
At week 52, 59.0% of patients with anemia at baseline had improvements in hemoglobin concentration of greater than 2 g/dL. Distress due to uterine leiomyoma-associated symptoms measured by the BPD (Bleeding and Pelvic Discomfort) scale score was reduced by 51.3 points. ...
At week 52, 59.0% of patients with anemia at baseline had improvements in hemoglobin concentration of greater than 2 g/dL. Distress d …
Endometriosis: seeking optimal management in women approaching menopause.
Alio L, Angioni S, Arena S, Bartiromo L, Bergamini V, Berlanda N, Bonanni V, Bonin C, Buggio L, Candiani M, Centini G, D'Alterio MN, De Stefano F, Di Cello A, Exacoustos C, Fedele L, Frattaruolo MP, Geraci E, Lavarini E, Lazzeri L, Luisi S, Maiorana A, Makieva S, Maneschi F, Martire F, Massarotti C, Mattei A, Muzii L, Ottolina J, Pagliardini L, Perandini A, Perelli F, Pino I, Porpora MG, Remorgida V, Scagnelli G, Seracchioli R, Solima E, Somigliana E, Sorrenti G, Ticino A, Venturella R, Viganò P, Vignali M, Zullo F, Zupi E. Alio L, et al. Climacteric. 2019 Aug;22(4):329-338. doi: 10.1080/13697137.2018.1549213. Epub 2019 Jan 10. Climacteric. 2019. PMID: 30628469 Review.
Vehicle Systems and Excipients Used in Minipig Drug Development Studies.
Weaver ML, Grossi AB, Schützsack J, Parish J, Løgsted J, Bøgh IB, Cameron D, Harvey W, Festag M, Downes N, Venturella S, Schlichtiger J, Mhedhbi S, Ross V, Kissner T, Stark C, Milano S, Heining P, Sanchez-Felix M. Weaver ML, et al. Toxicol Pathol. 2016 Apr;44(3):367-72. doi: 10.1177/0192623315613088. Epub 2015 Dec 16. Toxicol Pathol. 2016. PMID: 26674803 Review.
The review includes vehicles tolerated for single or multiple dosing by the Gottingen minipig, some of which are not appropriate for administration to other common nonrodent species (e.g., dogs). By presenting these data for dermal, oral, subcutaneous, and intravenous rout …
The review includes vehicles tolerated for single or multiple dosing by the Gottingen minipig, some of which are not appropriate for adminis …
State of the art and emerging drug therapies for female infertility.
Venturella R, Vaiarelli A, Cimadomo D, Pedri S, Lico D, Mazzilli R, Mocciaro R, Rienzi L, Di Carlo C, Ubaldi FM, Zullo F. Venturella R, et al. Gynecol Endocrinol. 2019 Oct;35(10):835-841. doi: 10.1080/09513590.2019.1603289. Epub 2019 Apr 29. Gynecol Endocrinol. 2019. PMID: 31032671 Review.
Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.
Ubaldi FM, Cimadomo D, Vaiarelli A, Fabozzi G, Venturella R, Maggiulli R, Mazzilli R, Ferrero S, Palagiano A, Rienzi L. Ubaldi FM, et al. Front Endocrinol (Lausanne). 2019 Feb 20;10:94. doi: 10.3389/fendo.2019.00094. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30842755 Free PMC article. Review.
Future strategies and tools are in the pipeline that might minimize the risks of AMA through non-invasive approaches for embryo selection (e.g., molecular analyses of leftover products of IVF, such as spent culture media). ...We also reviewed emerging experimental therapeu …
Future strategies and tools are in the pipeline that might minimize the risks of AMA through non-invasive approaches for embryo selection (e …
Cytotoxicity of extracts and compounds isolated from Croton echioides in animal tumor cell (HTC).
Vendruscolo I, Venturella SRT, Bressiani PA, Marco IG, Novello CR, Almeida IV, Vicentini VEP, Mello JCP, Düsman E. Vendruscolo I, et al. Braz J Biol. 2022 Sep 26;82:e264356. doi: 10.1590/1519-6984.264356. eCollection 2022. Braz J Biol. 2022. PMID: 36169527 Free article.
The semi-purified fractions showed cytotoxicity at concentrations above 200 g/mL, at 24, 48 and 72 hours, reaching cell viability of 24.78% [400 g/mL] at 24 hours, 12.79% [500 g/mL] at 48 hours and 10.57% [300 g/mL] at 72 hours. ...The clerodan diterpe …
The semi-purified fractions showed cytotoxicity at concentrations above 200 g/mL, at 24, 48 and 72 hours, reaching cell viability of …
Mushroom-Based Supplements in Italy: Let's Open Pandora's Box.
Risoli S, Nali C, Sarrocco S, Cicero AFG, Colletti A, Bosco F, Venturella G, Gadaleta A, Gargano ML, Marcotuli I. Risoli S, et al. Nutrients. 2023 Feb 2;15(3):776. doi: 10.3390/nu15030776. Nutrients. 2023. PMID: 36771482 Free PMC article.
Samples containing Ganoderma, labeled in the commercial product as G. lucidum, showed sequences that showed homology of 100% and 99% with G. resinaceum and G. sichuanense. ...
Samples containing Ganoderma, labeled in the commercial product as G. lucidum, showed sequences that showed homology of 100% and 99% …
Potential Activity of Albino Grifola frondosa Mushroom Extract against Biofilm of Meticillin-Resistant Staphylococcus aureus.
Fasciana T, Gargano ML, Serra N, Galia E, Arrigo I, Tricoli MR, Diquattro O, Graceffa G, Vieni S, Venturella G, Giammanco A. Fasciana T, et al. J Fungi (Basel). 2021 Jul 10;7(7):551. doi: 10.3390/jof7070551. J Fungi (Basel). 2021. PMID: 34356930 Free PMC article.
We obtained not only a significant reduction of OD score between biofilm and biofilm plus albino G. frondosa extract group, but also a reduction of category of biofilm. In addition, we observed a significant presence of isolates with strong category for the biofilm group a …
We obtained not only a significant reduction of OD score between biofilm and biofilm plus albino G. frondosa extract group, but also …
29 results